Aminoglycosides

overview

·      discovered in 1940's

·      derived from soil bacteria

·      effective against vast majority of gram-negative bacilli

mechanism of activity

·      multifactorial bacteriocidal effect

·      bind to gram-negative bacterial cell wall and affect permeability

·      actively taken up and concentrated by bacteria

·      bind to bacterial ribosomes and affect protein synthesis

in vitro activity
Time course

·      concentration-dependent killing

·      one single bolus dose works better than divided doses in 24 hrs

Postantibiotic effect

·      persistent suppression of bacterial growth after short antimicrobial exposure

·      continues for 2-3 hrs after exposure to aminoglycoside removed

·      concentration-dependent

Antimicrobial synergy

·      synergy between aminoglycoside and cell wall active microbial (penicillin, cephalosporin) for gram-positive cocci

pharmacology

·      administered IV over 30 min or IM (completely absorbed in 30-90 min)

·      minimal absorption from GIT

·      wide volume of distribution

·      poorly protein bound and very water soluble

·      cross membranes poorly

·      traverse blood-brain barrier poorly

·      exception is renal tubular and inner ear cells

·      enters synovial fluid easily

·      not  metabolised

·      99% excreted unchanged in kidney

toxicity

·      allergies rare

·      can cause

·      injury to renal proximal convoluted tubules

·      damage to cochlea and vestibular apparatus

·      appears to be less with once-daily dose

clinical indications

·      aerobic G- bacillus

·      Klebsiella

·      Enterobacter

·      Serratia

·      Pseudomonas aeruginosa (tobramicin)

·      aerobic G+ cocci

·      Strep viridans

·      Staph aureus (methicillin sensitive)

·      Staph epidermidis

·      Enterococcus

·      with penicillin or cephalosporin

·      resistance rare

dosage
Multiple daily dose

·      loading dose of 2 mg/kg and then 1.7 mg/kg q8h

·      aim for peak of 4-10 and trough of < 2

Once daily dose

·      clinical data not adequate to support unqualified endorsement

Premise

·      nephrotoxicity and ototoxicity less severe

·      PAE demonstrated which is peak concentration-dependent

·      antibacterial efficacy enanced with high peak drug concentration

Dosing

·      dose is 4-5 mg/kg over 60 min

·      peak levels not required

·      level at 18 hrs to check trough